World’s Vaccine Stocks May Expire as Supply Surpasses Demand

Vials of the COVID-19 vaccine by Moderna (C) and Pfizer/BioNTech against the novel coronavirus stand on a table in a vaccination center in Sonthofen, Germany, on Nov. 30, 2021. Christof Stache/AFP via Getty Images

COVID-19 vaccine stocks may go out of date as demand has dipped below supply, according to the globe’s largest manufacturer of jabs.

Adar Poonawalla, chief executive of the Serum Institute of India, on Sunday said the world had stockpiled more COVID-19 jabs than it can use as some of the developing countries are not placing orders.